What drove NOVN.SW stock’s after-hours activity on 09 Feb 2026?

After-hours interest in NOVN.SW stock followed strong intraday volume of **3,339,717** shares, price near the 52-week high, and sector momentum. Technical strength and pipeline news amplified trading; no single headline explained the full move

How does Novartis’ valuation look for NOVN.SW stock?

NOVN.SW stock trades at **P/E 21.61** with free cash flow yield **5.68%** and Price/Sales **5.21**. The company’s ROE **34.31%** supports valuation, but higher PB indicates a premium versus some peers

What price targets and outlook does Meyka AI provide for NOVN.SW stock?

Meyka AI's forecast model projects **monthly CHF123.14 (+2.45%)**, **yearly CHF108.32 (-9.88%)**, and **5-year CHF133.35 (+10.94%)** versus **CHF120.20** now. Forecasts are model-based projections and not guarantees

Should investors treat the Meyka grade as advice for NOVN.SW stock?

Meyka AI assigns **Score 77.95, Grade B+, Suggestion: BUY** for NOVN.SW stock; this summarizes quantitative and sector factors. It is informational only and not personalized investment advice

CH Stocks

Novartis AG (NOVN.SW) CHF120.20 after-hours 09 Feb 2026: most-active stock insight

ByHuzaifa Zahoor February 9, 2026

NOVN.SW stock opened the after-hours session on 09 Feb 2026 at CHF120.20, trading as one of the most-active Swiss healthcare names on the SIX. Volume reached 3,339,717 shares, above the 3-month average of 3,094,948, and the price sits near the 52-week high of CHF120.64. Traders are watching fundamentals — EPS CHF5.55 and P/E 21.61 — alongside technicals showing short-term strength. Meyka AI’s real-time system flagged the move as high-activity, linking news flow and sector momentum to the stock’s intraday gains